Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy.

Saved in:
Bibliographic Details
Title: Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy.
Authors: Nikitas J; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: John.Nikitas@pennmedicine.upenn.edu., Ma TM; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Cook K; Compass Oncology, Portland, OR, USA., Woods K; Department of Radiation Oncology, University of Southern California, Los Angeles, CA, USA., Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Reddy VK; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Hegde JV; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., St John M; Department of Head and Neck Surgery, University of California, Los Angeles, Los Angeles, CA, USA., Chai-Ho W; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Wong D; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Chu FI; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: FChu@mednet.ucla.edu., Felix C; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Tenn S; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Sheng K; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA., Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Kadowaki JY; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Pham J; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., O'Connell DP; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Cao M; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA., Chin RK; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: RKChin@mednet.ucla.edu.
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2026 Jan; Vol. 214, pp. 111283. Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0887
DOI:10.1016/j.radonc.2025.111283